Product Description
The Indian dental implant and final abutment market was valued at over $152 million in 2024. This is expected to increase over the forecast period at a CAGR of 12.5% to reach over $348 million.
The full report suite on the Indian market for dental implants and final abutments includes dental implants, final abutments, treatment planning software and surgical guides.
DATA TYPES INCLUDED IN THIS REPORT
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
INDIAN DENTAL IMPLANT MARKET TRENDS
- Straumann Group was the leading competitor in the dental implant and final abutment market in 2024. The company benefits from strong brand recognition and a proven track record of developing best-in-class dental implants. In 2024, Straumann held the second-highest share of the premium implant segment, driven by a comprehensive suite of dental implant-related products that support a wide range of clinical applications. Straumann’s subsidiary, Neodent, has also outperformed the market average in the value implant segment, further reinforcing Straumann’s position as a clear market leader. The company is well positioned to maintain its leadership in the dental implant industry, supported by a consistent focus on mergers and acquisitions that have significantly enhanced its overall portfolio and global presence
- Envista, the parent company of Nobel Biocare and Implant Direct, secured the second spot in the market. With a stronghold in the final abutment segment, Envista’s strategic differentiation offers growth opportunities, supported by factors like an aging population and dental digitization.
- Osstem Implant was the third-leading competitor in the Indian dental implant and final abutment market in 2024. The company’s core business focuses on manufacturing and supplying dental implants within the value implant segment. Its implant fixture portfolio includes four main systems: TS System®, SS System®, US System® and MS System®. Osstem Implant continues to increase its investment in research and development, driving innovation across its product lines. The company is expected to grow its market share due to several factors. By maintaining a strong focus on R&D to develop cutting-edge products, Osstem aims to expand its consumer base and offer solutions for a wide range of dental implant procedures. The recent introduction of NHIS coverage is likely to drive industry consolidation, which should benefit Osstem given its stronger financial resources and sales capabilities compared to smaller domestic manufacturers. Additionally, Osstem’s efforts to expand its global sales network, advance its AIC education programs and implement vigorous marketing strategies are expected to further boost its market share in the near future.
MARKET SEGMENTATION SUMMARY
- Dental Implants Market – Further Segmented Into:
- Type: Premium, Value, Discount.
- Shape: Parallel Wall, Tapered.
- Material: Titanium, Ceramic/Zirconia.
- Procedure Type: One-stage, Two-stage, Immediate Loading.
- Connection Type: Internal Connection, External Connection, One-Piece.
- Application: Single-Tooth Application, Multi-Tooth Bridge Partial Arch Securement, Multi-Tooth Bridge Full Arch Securement, Denture Securement.
- Final Abutment Market – Further Segmented Into:
- Fabrication: Stock, Custom Cast, CAD/CAM.
- Material: Titanium, Ceramic/Zirconia, Gold.
- Type: Cement-Retained, Screw-Retained, Denture Retaining.
- Instrument Kit Market
- Treatment Planning Software Market
- Surgical Guide Market
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | India |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
